These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17223022)

  • 1. Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.
    Charlton S; Jones NS; Davis SS; Illum L
    Eur J Pharm Sci; 2007 Mar; 30(3-4):295-302. PubMed ID: 17223022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
    Charlton ST; Davis SS; Illum L
    J Control Release; 2007 Apr; 118(2):225-34. PubMed ID: 17261340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.
    Charlton ST; Davis SS; Illum L
    Int J Pharm; 2007 Jun; 338(1-2):94-103. PubMed ID: 17337137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy.
    McInnes FJ; O'Mahony B; Lindsay B; Band J; Wilson CG; Hodges LA; Stevens HN
    Eur J Pharm Sci; 2007 May; 31(1):25-31. PubMed ID: 17368006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal clearance in health and disease.
    Illum L
    J Aerosol Med; 2006; 19(1):92-9. PubMed ID: 16551220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal route and drug delivery systems.
    Türker S; Onur E; Ozer Y
    Pharm World Sci; 2004 Jun; 26(3):137-42. PubMed ID: 15230360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance characteristics of chitosan based formulations in the sheep nasal cavity.
    Soane RJ; Hinchcliffe M; Davis SS; Illum L
    Int J Pharm; 2001 Apr; 217(1-2):183-91. PubMed ID: 11292554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine.
    Chelladurai S; Mishra M; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Nov; 56(11):1596-9. PubMed ID: 18981612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal delivery of insulin using bioadhesive chitosan gels.
    Varshosaz J; Sadrai H; Heidari A
    Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump.
    Djupesland PG; Skretting A
    J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):280-9. PubMed ID: 22251061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS; Purewal TS; Alpar OH
    J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Evaluation of a Novel Intranasal Spray for the Delivery of Amantadine.
    Lungare S; Bowen J; Badhan R
    J Pharm Sci; 2016 Mar; 105(3):1209-20. PubMed ID: 26886345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Site-specific drug delivery systems. III. Nasal drug delivery].
    Szente V; Zelkó R
    Acta Pharm Hung; 2008; 78(2):87-90. PubMed ID: 18807389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the clearance characteristics of bioadhesive systems in humans.
    Soane RJ; Frier M; Perkins AC; Jones NS; Davis SS; Illum L
    Int J Pharm; 1999 Feb; 178(1):55-65. PubMed ID: 10205625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma scintigraphy for testing bioequivalence: a case study on two cromolyn sodium nasal spray preparations.
    Al-Ghananeem AM; Sandefer EP; Doll WJ; Page RC; Chang Y; Digenis GA
    Int J Pharm; 2008 Jun; 357(1-2):70-6. PubMed ID: 18329197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophilic nasal gel of lidocaine hydrochloride. 2nd communication: Improved bioavailability and brain delivery in rats with low ciliotoxicity.
    Hu KL; Mei N; Feng L; Jiang XG
    Arzneimittelforschung; 2009; 59(12):635-40. PubMed ID: 20108649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation Development and Evaluation of Lyophilized Nasal Inserts for Migraine Treatment.
    Harshada SD; Mundada AS
    Recent Pat Drug Deliv Formul; 2017; 11(1):42-53. PubMed ID: 28103774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal delivery of morphine.
    Illum L; Watts P; Fisher AN; Hinchcliffe M; Norbury H; Jabbal-Gill I; Nankervis R; Davis SS
    J Pharmacol Exp Ther; 2002 Apr; 301(1):391-400. PubMed ID: 11907197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nano-cellulose excipient for generating non-Newtonian droplets for targeted nasal drug delivery.
    Young PM; Traini D; Ong HX; Granieri A; Zhu B; Scalia S; Song J; Spicer PT
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1729-1733. PubMed ID: 28581833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan in nasal delivery systems for therapeutic drugs.
    Casettari L; Illum L
    J Control Release; 2014 Sep; 190():189-200. PubMed ID: 24818769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.